NeuroMetrix, Inc. (NASDAQ:NURO) Sees Significant Decrease in Short Interest

NeuroMetrix, Inc. (NASDAQ:NURO) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 31,100 shares, a decline of 26.7% from the November 15th total of 42,400 shares. Approximately 2.1% of the company’s stock are short sold. Based on an average daily trading volume, of 17,600 shares, the short-interest ratio is presently 1.8 days.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on NeuroMetrix in a research note on Friday, December 6th. They issued a “sell” rating on the stock.

NeuroMetrix Price Performance

Shares of NASDAQ NURO traded down $0.09 during trading hours on Friday, hitting $3.81. 6,006 shares of the stock were exchanged, compared to its average volume of 24,678. NeuroMetrix has a one year low of $2.66 and a one year high of $4.73. The company’s 50 day moving average is $4.09 and its 200 day moving average is $3.84. The firm has a market capitalization of $7.77 million, a P/E ratio of -0.85 and a beta of 2.18.

NeuroMetrix (NASDAQ:NURO) last issued its quarterly earnings results on Tuesday, November 5th. The medical device company reported ($0.75) earnings per share (EPS) for the quarter. NeuroMetrix had a negative net margin of 203.71% and a negative return on equity of 42.56%. The business had revenue of $0.59 million during the quarter. During the same quarter in the prior year, the company posted ($1.66) earnings per share.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.